Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

Obesity, overweight up risk of complications from radical cystectomy
Body mass index is independently associated with the development of complications from radical cystectomy, reports a study. Compared to patients with normal BMI, those who are overweight and obese have a higher risk.
Obesity, overweight up risk of complications from radical cystectomy
20 Dec 2022
EMERALD updates highlight therapeutic potential of elacestrant for ER+/HER2– mBC
In the updated analysis of the phase III EMERALD trial, the next-generation oral SERD* elacestrant continued to show favourable signals for the treatment of ER+/HER2– metastatic breast cancer (mBC).
EMERALD updates highlight therapeutic potential of elacestrant for ER+/HER2– mBC
20 Dec 2022
Metformin may reduce COVID-19 severity in prediabetes, PCOS
Among patients with prediabetes or polycystic ovary syndrome (PCOS), the use of metformin appears to be associated with lower incidence of severe COVID-19, according to a study.
Metformin may reduce COVID-19 severity in prediabetes, PCOS
19 Dec 2022
Bepirovirsen shows promise in controlling chronic HBV infection
Weekly bepirovirsen treatment may help reduce HBsAg* and hepatitis B virus (HBV) DNA levels in patients with chronic HBV infection, the phase IIb B-Clear study showed.
Bepirovirsen shows promise in controlling chronic HBV infection
19 Dec 2022
Can vitamin D ease overactive bladder, urinary incontinence symptoms in older men?
Supplementation with vitamin D does not lead to improvements in overactive bladder or urinary incontinence relative to placebo, a study has shown. However, specific use of vitamin D in men with lower 25-hydroxyvitamin D levels shows inconsistent results.
Can vitamin D ease overactive bladder, urinary incontinence symptoms in older men?
19 Dec 2022
Maintenance olaparib confers survival benefit for HRD+ ovarian cancer patients
In the final overall survival (OS) analysis of the phase III PAOLA-1*/ENGOT-ov25 trial, the addition of olaparib to bevacizumab provided a survival benefit for women with newly diagnosed advanced ovarian cancer with HRD**-positive (HRD+) tumours.



